Search for: "K-V Pharmaceutical Company" Results 1 - 20 of 225
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2012, 5:00 am by Lisa Salazar
By Bob Rouder and Saul PerloffIn February, 2011, K-V Pharmaceuticals received FDA approval to market its branded pregnancy drug, Makena® as an orphan drug. [read post]
9 Nov 2012, 10:07 am
K-V Pharmaceutical Company ("K-V") has taken the fight over its preterm-birth prevention drug, Makena® (17-hydroxypreogesterone caproate solution) ("HPC"), to the International Trade Commission ("ITC"). [read post]
17 Aug 2011, 7:00 pm by Seth Leventhal
Original Post (April 22, 2011):  K-V Pharmaceutical, a Missouri company, had a multi-year business relationship with J. [read post]
7 Feb 2012, 6:59 am by Edward M. McNally
K-V Pharmaceutical Company,  C.A. 6936-VCG (February 7, 2012) This is the leading decision on how to establish the "good faith" requirement for permissive indemnification after the indemnitee has lost his case. [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
The complaint also names Allergan plc, the parent company of Watson, and Endo International plc, the parent company of Endo Pharmaceuticals Inc. [read post]
1 Feb 2011, 4:01 am by Maxwell Kennerly
There's been a wave of antitrust class actions predicated on patent misuse by pharmaceutical companies of the past decade. [read post]
3 Mar 2019, 12:38 pm
(MGI), a Minnesota pharmaceutical company that markets and distributes drugs in the United States. [read post]
26 Mar 2013, 5:17 pm by Prashant Reddy
Yu was Assistant General Counsel, Litigation for Affymetrix, Inc., the first company to commercialize DNA microarrays.Federal Trade Commission v. [read post]
15 Sep 2011, 4:06 am by Maxwell Kennerly
It’s no secret that pharmaceutical companies are among the more litigious businesses in America. [read post]
7 Oct 2015, 12:35 pm by Beth Graham
In the pending investor-state-dispute-settlement case under an older but parallel North America Free Trade Agreement (NAFTA) investment clause, an American pharmaceutical company, in Eli Lilly v. [read post]